immunotherapy, cytotoxicity, tumor vaccine, prostate cancer, radiotherapy
Showing 1 - 25 of >10,000
Advanced Non-Small Cell Squamous Lung Cancer, Radiotherapy, Immunotherapy Trial in Wuhan (CTV omitted or delineated)
Not yet recruiting
- Advanced Non-Small Cell Squamous Lung Cancer
- +2 more
- CTV omitted or delineated
-
Wuhan, Hubei, ChinaHubei Cancer Hospital
Sep 7, 2023
Metastatic Prostate Cancer, Prostate Cancer, Prostate Tumor Trial run by the NCI (M7824, N-803, MVA-BN-Brachyury)
Recruiting
- Metastatic Prostate Cancer
- +4 more
- M7824
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Prostate Cancer, Prostate Disease Trial in Tampa (Nivolumab, Brachytherapy, External Beam Radiation Therapy)
Recruiting
- Prostate Cancer
- Prostate Disease
- Nivolumab
- +3 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Nov 11, 2022
Metastatic Hormone-Sensitive Prostate Cancer Trial in Saint Louis (biological, drug, device, procedure)
Completed
- Metastatic Hormone-Sensitive Prostate Cancer
- PROSTVAC-V
- +9 more
-
Saint Louis, MissouriWashington University School of Medicine
Aug 3, 2022
Tumor Recurrence Following Radiotherapy
Recruiting
- Prostate Cancer
-
Rochester, MinnesotaMayo Clinic
Jan 20, 2023
Prostate Cancer, Prosatatic Tumor Trial run by the National Cancer Institute (NCI) (18F-DCFPyL, Tumor Irradiation, Prostate +
Recruiting
- Prostate Cancer
- Prosatatic Neoplasm
- 18F-DCFPyL
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Apr 7, 2022
ABlative Radiotherapy (for) Unfavorable Prostate Tumors
Recruiting
- Prostate Cancer
-
Monza, MB, ItalyRadiation Oncology, ASST Monza (University of Milan Bicocca)
Jul 21, 2022
Metastatic Tumor Trial in Prince George, London, Montréal (radiation, drug, other, procedure)
Not yet recruiting
- Metastatic Tumor
- Palliative Radiotherapy
- +9 more
-
Prince George, British Columbia, Canada
- +2 more
Feb 6, 2023
Metastatic Castration Resistant Prostate Cancer, Metastatic Cancer, Solid Tumor Trial in United States (Nivolumab, Ipilimumab)
Active, not recruiting
- Metastatic Castration Resistant Prostate Cancer
- +2 more
-
San Diego, California
- +7 more
Jan 23, 2023
Refractory Tumor, Solid Tumor Trial in Kaohsiung, Tainan (Dendritic Cell Vaccine, Lenvatinib, Nivolumab)
Not yet recruiting
- Refractory Tumor
- Solid Tumor
- Dendritic Cell Vaccine
- +2 more
-
Kaohsiung, Taiwan
- +2 more
Mar 2, 2023
Online Adaptive Radiotherapy UsingNovel Linear Accelerator
Recruiting
- Prostate Cancer
- +8 more
- Online adaptive radiation therapy
-
Berlin, GermanyCharité - Universitätsmedizin
Oct 30, 2023
Newly Diagnosed Oligometastatic Prostate Cancer Trial in Long Beach, West Los Angeles, Richmond (procedure, radiation, drug)
Active, not recruiting
- Newly Diagnosed Oligometastatic Prostate Cancer
- radical prostatectomy
- +4 more
-
Long Beach, California
- +2 more
Mar 16, 2022
Prostate Cancer, Bladder Cancer, NSCLC Trial in New York, Houston (NY-ESO-1 Plasmid DNA Cancer Vaccine)
Completed
- Prostate Cancer
- +4 more
- NY-ESO-1 Plasmid DNA Cancer Vaccine
-
New York, New York
- +1 more
Oct 3, 2022
Mesothelioma, Pleural Mesothelioma, Wilms Tumor Trial in United States (Galinpepimut-S, Nivolumab, Sargramostim)
Active, not recruiting
- Mesothelioma
- +2 more
- Galinpepimut-S
- +2 more
-
Basking Ridge, New Jersey
- +5 more
Nov 23, 2022
Prostate Cancer Trial in Toronto (Volumetric Modulated Arc Therapy (VMAT) and High-Dose Rate (HDR) Radiotherapy, No Active
Active, not recruiting
- Prostate Cancer
- Volumetric Modulated Arc Therapy (VMAT) and High-Dose Rate (HDR) Radiotherapy
- No Active Treatment - completed Prior Radiation
-
Toronto, Ontario, CanadaUniversity Health Network, The Princess Margaret
Oct 4, 2021
Prostate Cancer, Prostate Adenocarcinoma Trial in Miami (Standard Salvage Radiation Treatment (SSRT), Mapped Tumor Salvage RT
Recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
- Standard Salvage Radiation Treatment (SSRT)
- Mapped Tumor Salvage RT (MTSRT)
-
Miami, FloridaUniversity of Miami
Dec 1, 2021
Prostate Cancer, 18F- Fluorocholine, PSMA PET Trial (Radiopharmaceutical 18F-JK-PSMA-7, Radiopharmaceutical 18F-Fluorocholine)
Not yet recruiting
- Prostate Cancer
- +5 more
- Radiopharmaceutical 18F-JK-PSMA-7
- Radiopharmaceutical 18F-Fluorocholine
- (no location specified)
Nov 17, 2022
Prostate Cancer Trial in Shanghai (drug, procedure, radiation)
Recruiting
- Prostate Cancer
- Leuprolide acetate
- +9 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Mar 15, 2022
Malignant Tumors of Brain Trial in Durham (tetanus toxoid, therapeutic autologous dendritic cells, therapeutic autologous
Active, not recruiting
- Malignant Neoplasms of Brain
- tetanus toxoid
- +2 more
-
Durham, North CarolinaDuke University Medical Center
Aug 16, 2022
Prostate Cancer Trial in Toronto (whole-mount sectioning of the prostate)
Active, not recruiting
- Prostate Cancer
- whole-mount sectioning of the prostate
-
Toronto, Ontario, CanadaUniversity Health Network
Oct 4, 2021
Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified, Stage IB3 Cervical Cancer FIGO 2018, Stage II
Recruiting
- Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified
- +13 more
- Cisplatin
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Mar 31, 2022
Prostatic Tumors, Prostatic Cancer Trial run by the NCI (ETBX-071; adenoviral PSA vaccine, ETBX-061; adenoviral MUC1 vaccine,
Completed
- Prostatic Neoplasms
- Prostatic Cancer
- ETBX-071; adenoviral PSA vaccine
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Apr 28, 2021
Head and Neck Squamous Cell Carcinoma, Cancer, Cancer of Head and Neck Trial in United States (Pembrolizumab, Radiation therapy,
Recruiting
- Head and Neck Squamous Cell Carcinoma
- +14 more
- Pembrolizumab
- +2 more
-
Tucson, Arizona
- +6 more
Oct 7, 2021
Malignant Solid Tumour, Breast Cancer, Malignant Tumor of Colon Trial in Columbus (HER-2 vaccine, Extension HER-2 vaccine trial
Recruiting
- Malignant Solid Tumour
- +4 more
- HER-2 vaccine
- Extension HER-2 vaccine trial at OBD
-
Columbus, OhioOhio State University Medical Center
Oct 26, 2021